Recent news on Saquinavir Mesylate

Interim Analysis of New Study Suggests Boosted Saquinavir Mesylate ...  -  Nov 13, 2006
DG News500 mg/r (saquinavir mesylate) has the potential to achieve comparable levels of viral suppression to the most commonly used PI, lopinavir/r (Kaletra®),

Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May ...  -  Nov 14, 2006
Medical News Today (press release),Encouraging results from an interim analysis of a new study suggest that the boosted protease inhibitor (PI/r) INVIRASE(R) 500 mg/r (saquinavir mesylate)

Good Long-term Efficacy and Safety With Once-Daily Ritonavir ...  Aug 18, 2006
...[Presentation title: Long-term Efficacy and Safety of Once-Daily Ritonavir-Boosted Saquinavir Mesylate (SQV/r) Plus 2 NRTIs. Abstract WEPE0110]. -DG News

A Quarter Century of Battling HIV/AIDS  Jul 21, 2006
The year 1995 marked the beginning of another era, that of the protease inhibitors, the first of which was Invirase (saquinavir mesylate, SQV) from Roche ... -Drug Discovery & Development



International Approvals: Invirase and Remicade  May 15, 2006
May 15, 2006 — Health Canada has approved a 500-mg tablet formulation of saquinavir mesylate that significantly reduces the daily pill count for patients ... - Medscape (subscription)

Roche Women Honored as 2006 TWIN Awardees  Apr 28, 2006
She led the FDA filings for the early AIDS drugs HIVID® (zalcitabine) and Invirase® (saquinavir mesylate), which positively affected the lives of countless ... - Yahoo! News





UPDATE 1-Roche to discontinue US sales of AIDS drug  Feb 6, 2006
Roche said its Invirase (saquinavir mesylate) HIV drug in 500 milligram tablet form is the preferred medicine as part of a combination treatment to prevent ... - Reuters

Roche to Focus Resources on Availability of Invirase, Now ...  Feb 6, 2006
Invirase® (saquinavir mesylate) capsules and Fortovase® (saquinavir) soft gelatin capsules are not bioequivalent and cannot be used interchangeably. ... - DG News

UPDATE 1-Roche to discontinue US sales of AIDS drug  Feb 6, 2006
Roche said its Invirase (saquinavir mesylate) HIV drug in 500 milligram tablet form is the preferred medicine as part of a combination treatment to prevent ... - Reuters

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional